Vanda Pharmaceuticals Inc. (VNDA) stock
VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.81+0.00 (0.00%)
Close on Nov 17, 2026Market cap $230.39MP/E –Yield –
Vanda Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2014 it was $20.59M. The highest annual figure on record is $20.59M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $20.59M | – |
| FY2013 | Dec 31, 2013 | -$20.77M | – |
| FY2012 | Dec 31, 2012 | -$28.55M | – |
| FY2011 | Dec 31, 2011 | -$10.24M | -211.6% |
| FY2010 | Dec 31, 2010 | $9.17M | – |
| FY2009 | Dec 31, 2009 | -$35.51M | – |
See a number that looks wrong?